Division of Hematology/Oncology, Northwestern University, Chicago, IL, USA
Division of Hematology/Oncology, Northwestern University, Chicago, IL, USA.
EMBO Rep. 2018 Mar;19(3). doi: 10.15252/embr.201745336. Epub 2018 Feb 12.
Trinucleotide repeat (TNR) expansions in the genome cause a number of degenerative diseases. A prominent TNR expansion involves the triplet CAG in the huntingtin (HTT) gene responsible for Huntington's disease (HD). Pathology is caused by protein and RNA generated from the TNR regions including small siRNA-sized repeat fragments. An inverse correlation between the length of the repeats in HTT and cancer incidence has been reported for HD patients. We now show that siRNAs based on the CAG TNR are toxic to cancer cells by targeting genes that contain long reverse complementary TNRs in their open reading frames. Of the 60 siRNAs based on the different TNRs, the six members in the CAG/CUG family of related TNRs are the most toxic to both human and mouse cancer cells. siCAG/CUG TNR-based siRNAs induce cell death in all tested cancer cell lines and slow down tumor growth in a preclinical mouse model of ovarian cancer with no signs of toxicity to the mice. We propose to explore TNR-based siRNAs as a novel form of anticancer reagents.
三核苷酸重复(TNR)扩展在基因组中导致许多退行性疾病。一个突出的 TNR 扩展涉及到亨廷顿病(HD)相关的 HTT 基因中的三核苷酸 CAG。病理学是由 TNR 区域产生的蛋白质和 RNA 引起的,包括小 siRNA 大小的重复片段。据报道,HD 患者的 HTT 重复长度与癌症发病率呈负相关。我们现在表明,基于 CAG TNR 的 siRNA 通过靶向其开放阅读框中含有长反向互补 TNR 的基因对癌细胞有毒。在基于不同 TNR 的 60 个 siRNA 中,CAG/CUG 家族的六个成员对人和小鼠癌细胞最毒。基于 siCAG/CUG TNR 的 siRNA 在所有测试的癌细胞系中诱导细胞死亡,并减缓卵巢癌临床前小鼠模型中的肿瘤生长,对小鼠没有毒性迹象。我们建议探索基于 TNR 的 siRNA 作为一种新形式的抗癌试剂。